BioAdaptives, Inc. Redefines Its Expanding Role of Providing Innovative Human Health Products While Its Wholly Owned Subsidiary, LiveStock Impact, Inc., Targets Animal Health and Botanical Drugs
LAS VEGAS, NV, Sept. 27, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today new directions and activities intended to expand the Company’s role in providing additional products for human health. Besides continuing to develop and market novel all natural supplement formulations for general use, BDPT is developing potential products that are designed to benefit more specific sectors such as Women’s and Men’s Health. Additional expansion under consideration includes the marketing of natural topical formulations based upon current ongoing research and certain functional foods with demonstrated health benefits.
Related news for (BDPT)
- BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements
- BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors
- BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders
- BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace
- bioadaptives, inc. announces complete product overhaul with new line of scientifically advanced solutions